Trudeau Institute

Health Research Incorporated, which is affiliated with the New York State Department of Health and the Roswell Park Cancer Institute, will help the Trudeau Institute establish its first real tech-transfer program to commercialize basic research on immune response to infectious disease.

Core lab facilities try to keep their customers' research competitive with high-quality data and cutting-edge tools, but budget concerns and choosing the right technology make it a balancing act. Here's how they do it.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.